对于接种过六价疫苗的儿童，无需进行乙肝疫苗加强接种以获得长期保护。 - Suppr | 超能文献

Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.

作者信息

Romanò L, Zanetti A R

出版信息

J Prev Med Hyg. 2011 Jun;52(2):45-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Booster hepatitis B vaccination not necessary for long-term protection in children immunised with hexavalent vaccines.

J Prev Med Hyg. 2011 Jun;52(2):45-6.

2

Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.

Lancet Infect Dis. 2010 Nov;10(11):755-61. doi: 10.1016/S1473-3099(10)70195-X. Epub 2010 Sep 29.

3

Loss of antibodies, but not of protection.

Lancet Infect Dis. 2010 Nov;10(11):738-9. doi: 10.1016/S1473-3099(10)70217-6.

4

Lasting immune memory against hepatitis B in 12-13-year-old adolescents previously vaccinated with 4 doses of hexavalent DTPa-HBV-IPV/Hib vaccine in infancy.

Hum Vaccin Immunother. 2016 Nov;12(11):2916-2920. doi: 10.1080/21645515.2016.1202388. Epub 2016 Sep 21.

5

Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.

Vaccine. 2007 Jan 22;25(6):1055-63. doi: 10.1016/j.vaccine.2006.09.060. Epub 2006 Oct 2.

6

Immune memory to hepatitis B persists in children aged 7-8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine.

Hum Vaccin Immunother. 2014;10(6):1682-7. doi: 10.4161/hv.28480. Epub 2014 Mar 17.

7

Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.

Vaccine. 2012 Aug 24;30(39):5770-5. doi: 10.1016/j.vaccine.2012.06.078. Epub 2012 Jul 9.

8

Hepatitis B specific T cell immunity induced by primary vaccination persists independently of the protective serum antibody level.

Vaccine. 2013 Jan 7;31(3):506-13. doi: 10.1016/j.vaccine.2012.11.029. Epub 2012 Nov 19.

9

Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy.

Vaccine. 2017 Jul 13;35(32):4034-4040. doi: 10.1016/j.vaccine.2017.05.047. Epub 2017 Jun 16.

10

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.

Vaccine. 2004 Jun 2;22(17-18):2226-33. doi: 10.1016/j.vaccine.2003.11.044.

引用本文的文献

1

Hepatitis B Seroprevalence in the Pediatric and Adolescent Population of Florence (Italy): An Update 27 Years after the Implementation of Universal Vaccination.

Vaccines (Basel). 2020 Mar 30;8(2):156. doi: 10.3390/vaccines8020156.

2

Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.

Hum Vaccin Immunother. 2013 Mar;9(3):636-41. doi: 10.4161/hv.23259. Epub 2013 Jan 25.